| 2023 | Park JY, Lee GH, Yoo KH, Khang D. Overcoming multidrug-resistant lung cancer by mitochondrial-associated ATP inhibition using nanodrugs. J Nanobiotechnology. 2023;21(1):12. |
| 2023 | Kim M, Lee JJ, Min CK, Lee JY, Jo JC, Yoon SS, et al. Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015). Annals of hematology. 2023;102(8):2233-40. |
| 2023 | Cho H, Yoon DH, Shin DY, Koh Y, Yoon SS, Kim SJ, et al. Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404). Cancer research and treatment : official journal of Korean Cancer Association. |
| 2023 | Kim DY, Kim YR, Suh C, Yoon DH, Yang DH, Park Y, et al. A prospective study of preemptive tenofovir disoproxil fumarate therapy in HBsAg-positive diffuse large B cell lymphoma patients receiving R-CHOP. Am J Gastroenterol. 2023. |
| 2022 | Yoo KH, Yoon DH, Kang HJ, Lee WS, Kim K, Kim JS, et al. Multicenter, phase II study of response-adapted lenalidomide-based therapy for transplant-ineligible patients with newly diagnosed multiple myeloma without high-risk features. Curr Probl Cancer. 2022;46(1):100788. |
| 2022 | Yoo KH. Staging and response assessment of lymphoma: a brief review of the Lugano classification and the role of FDG-PET/CT. Blood Res. 2022;57(S1):75-8. |
| 2022 | Hwang S, Kim SH, Yoo KH, Chung MH, Lee JW, Son KH. Exogenous 8-hydroxydeoxyguanosine attenuates doxorubicin-induced cardiotoxicity by decreasing pyroptosis in H9c2 cardiomyocytes. BMC Mol Cell Biol. 2022;23(1):55. |
| 2022 | Seo JY, Yoo KH, Hwang IC. Association between Height and Peripheral Blood Cell Count in Korean Adults. Iran J Public Health. 2022;51(10):2367-9. |
| 2022 | Yoon S, Yoo KH, Park SH, Kim H, Lee JH, Park J, et al. Low-dose abdominopelvic computed tomography in patients with lymphoma: An image quality and radiation dose reduction study. PLoS One. 2022;17(8):e0272356. |
| 2022 | Yi JH, Jeong SH, Kim SJ, Yoon DH, Kang HJ, Koh Y, et al. Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts. Cancer research and treatment : official journal of Korean Cancer Association. 2022. |
| 2021 | Yi JH, Lee GW, Lee JH, Yoo KH, Jung CW, Kim DS, et al. Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea. Blood Res. 2021;56(4):243-51. |
| 2021 | Yoo KH, Kim HJ, Min YH, Hong DS, Lee WS, Kim HJ, et al. Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry. PLoS One. 2021;16(5):e0251011. |
| 2021 | Kim H, Kim ST, Yoo KH, Hong JY, Park YS, Lim HY, et al. ATM Expression as a Prognostic Marker in Patients With Advanced Biliary Tract Cancer Treated With First-line Gemcitabine and Platinum Chemotherapy. In Vivo. 2021;35(1):499-505. |
| 2020 | Yoo KH, Cho J, Han B, Kim SH, Shin DY, Hong J, et al. Outcomes of decitabine treatment for newly diagnosed acute myeloid leukemia in older adults. PLoS One. 2020;15(8):e0235503. |
| 2020 | Jo JC, Kim SJ, Lee HS, Eom HS, Lee SI, Park Y, et al. Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report. Annals of hematology. 2020;99(2):223-8. |
| 2019 | Yoo KH, Lee SJ, Cho J, Lee KH, Park KU, Kim KH, et al. A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13. Cancer Res Treat. 2019;51(2):718-26. |
| 2019 | Kwon S, Yoo KH, Sym SJ, Khang D. Mesenchymal stem cell therapy assisted by nanotechnology: a possible combinational treatment for brain tumor and central nerve regeneration. Int J Nanomedicine. 2019;14:5925-42. |
| 2019 | Kwoun WJ, Ahn JY, Park PW, Seo YH, Kim KH, Seo JY, et al. How useful is bone marrow study as an initial investigative tool without lymph node biopsy in malignant lymphoma?: Eleven years of experience at a single institution. J Clin Lab Anal. 2019;33(4):e22841. |
| 2018 | Yoo KH, Lee H, Suh C. Lymphoma epidemiology in Korea and the real clinical field including the Consortium for Improving Survival of Lymphoma (CISL) trial. Int J Hematol. 2018;107(4):395-404. |
| 2018 | Yoo KH, Kang D, Kim IR, Choi EK, Kim JS, Yoon SS, et al. Satisfaction with sexual activity and sexual dysfunction in hematopoietic stem cell transplantation survivors and their partners: a couple study. Bone Marrow Transplant. 2018;53(8):967-76. |
| 2018 | Cho J, Kim SJ, Park S, Yoo KH, Ki CS, Ko Y, et al. Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphoma. Ann Hematol. 2018;97(8):1427-36. |
| 2017 | Kim C, Yoo KH, Kim MH, Chon HJ, Lee SI, Lee HJ, et al. Different subtypes of epithelioid sarcoma and their clinical implication: long-term multi-institutional experience with a rare sarcoma. Apmis. 2017;125(3):223-9. |
| 2016 | Yoo KH, Kim NK, Kwon WI, Lee C, Kim SY, Jang J, et al. Genomic Alterations in Biliary Tract Cancer Using Targeted Sequencing. Transl Oncol. 2016;9(3):173-8. |
| 2106 | Tay CK, Yoo KH, Cho YH. Intraaortic Balloon Pulsation in Peripheral Venoarterial Extracorporeal Membrane Oxygenation: More Is Not Always Better. Crit Care Med. 2016;44(12):e1251. |
| 2016 | Song HN, Jung KS, Yoo KH, Cho J, Lee JY, Lim SH, et al. Acquired C797S Mutation upon Treatment with a T790M-Specific Third-Generation EGFR Inhibitor (HM61713) in Non-Small Cell Lung Cancer. J Thorac Oncol. 2016;11(4):e45-7. |
| 2016 | Lee K, Kwon HJ, Kim IY, Yoo KH, Lee S, Min YW, et al. Esophageal Mast Cell Infiltration in a 32-Year-Old Woman with Noncardiac Chest Pain. Gut Liver. 2016;10(1):152-5. |
| 2016 | Lee JY, Sun JM, Lim SH, Kim HS, Yoo KH, Jung KS, et al. A Phase Ib/II Study of Afatinib in Combination with Nimotuzumab in Non-Small Cell Lung Cancer Patients with Acquired Resistance to Gefitinib or Erlotinib. Clin Cancer Res. 2016;22(9):2139-45. |
| 2016 | Lee JY, Lee I, Chang WJ, Ahn SM, Lim SH, Kim HS, et al. MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis. Oncotarget. 2016;7(28):43492-503. |
| 2016 | Kim HK, Ham JS, Byeon S, Yoo KH, Jung KS, Song HN, et al. Clinicopathologic Features and Long-Term Outcomes of Elderly Breast Cancer Patients: Experiences at a Single Institution in Korea. Cancer Res Treat. 2016;48(4):1382-8. |
| 2016 | Choi JW, Kong DS, Seol HJ, Nam DH, Yoo KH, Sun JM, et al. Outcomes of Gamma Knife Radiosurgery in Combination with Crizotinib for Patients with Brain Metastasis from Non-Small Cell Lung Cancer. World Neurosurg. 2016;95:399-405. |
| 2016 | Cho J, Ahn S, Yoo KH, Kim JH, Choi SH, Jang KT, et al. Treatment outcome of PD-1 immune checkpoint inhibitor in Asian metastatic melanoma patients: correlative analysis with PD-L1 immunohistochemistry. Invest New Drugs. 2016;34(6):677-84. |
| 2015 | Yoo KH, Lee JY, Lim SH, Ko YH, Kim SJ, Kim WS. Pilot trial of systemic methotrexate plus R-CHOP regimen with intrathecal methotrexate for simultaneous central nervous system and systemic diffuse large B cell lymphoma. Acta Haematol. 2015;133(2):179-82. |
| 2015 | Yoo KH, Kim HS, Lee SJ, Park SH, Kim SJ, Kim SH, et al. Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series. BMC Cancer. 2015;15:154. |
| 2015 | Lee JY, Park K, Lim SH, Kim HS, Yoo KH, Jung KS, et al. Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer. Oncotarget. 2015;6(41):43731-42. |
| 2015 | Kwon HJ, Yoo KH, Kim IY, Lee S, Jang HR, Kwon GY. Megalocytic interstitial nephritis following acute pyelonephritis with Escherichia coli bacteremia: a case report. J Korean Med Sci. 2015;30(1):110-4. |
| 2014 | Lee K, Park SJ, Kwon HJ, Kim IY, Yoo KH, Lee S, et al. Progressive increase in peridevice leakage after the implantation of the watchman device on long-term serial echocardiographic follow-up. Can J Cardiol. 2014;30(11):1461.e15-7. |
